Try our Advanced Search for more refined results
sa¹ú¼Ê´«Ã½
-
December 03, 2025
ITC Judge Finds Innoscience Infringes 1 Of 2 Infineon Patents
A U.S. International Trade Commission judge has found that China-based chipmaker Innoscience infringed upon a patent owned by semiconductor manufacturer Infineon Technologies, though Innoscience says the finding doesn't block it from selling its gallium nitride technology products.
-
December 03, 2025
Kevin O'Leary, Company Execs Fight Patent Forgery Suit
A livestock technology company and several of its executives and investors, including Kevin O'Leary of "Shark Tank," have asked a Colorado federal judge to throw out the lawsuit against them by the company's founder, who claims the defendants stole her company and intellectual property.
-
December 03, 2025
State AGs Condemn College Sports Rule Enforcement Deal
Seven state attorneys general on Wednesday called a proposed contract between NCAA institutions and the commission enforcing new revenue-sharing rules for athletes "cartoonishly villainous," arguing in a letter that it undermines state laws and jeopardizes the rights of athletes and schools.
-
December 03, 2025
Meta Accused Of Stealing Swedish Label's Music A 2nd Time
A Swedish music label has once again accused Meta of copyright infringement, saying the social media giant has not stopped encouraging users to insert its recordings into Reels and other videos on Facebook and Instagram without proper licensing since its first suit was filed.Â
-
December 03, 2025
Rag & Bone Gets Temporary Relief In Suit Over 'Miramar' Mark
Fashion brand Rag & Bone secured a temporary restraining order on Wednesday against an intellectual property holding company from asserting ownership over a trademark of the term "Miramar," saying Rag & Bone had shown it was likely to suffer irreparable harm without court intervention.
-
December 03, 2025
Novartis, Swiss Marketer Want Out Of Trade Secrets Suit
A Swiss marketing company and its founder have joined pharmaceutical giant Novartis in asking a Manhattan federal judge to release them from a hedge fund's suit accusing the founder of brokering business meetings with Novartis in a scheme to steal its strategy, claiming the suit is merely an attempt to punish Novartis for placing money with a competitor.
-
December 03, 2025
Fed. Circ. Backs Axed Claims In Heart Rate Monitor Patent
The Federal Circuit on Wednesday upheld a Utah federal court's decision that claims in a wireless heart rate monitor patent owned by Finnish sports tech company Polar Electro Oy were invalid under the U.S. Supreme Court's Alice test.
-
December 03, 2025
Judge Rejects X's Early Attempt To Block Minn. Deepfake Law
A Minnesota federal judge has denied X Corp.'s request for a favorable ruling in its challenge to a Minnesota state law curtailing the dissemination of "deepfakes" aimed at influencing elections, saying X had not shown that it could be harmed by the law in a manner that would give it standing to block it.
-
December 03, 2025
Nike 'Cool Compression' Case Not Exceptional, 3rd Circ. Told
Nike argued before the Third Circuit on Wednesday that its "cool compression" trademark litigation with clothing maker Lontex Corp. was not so "exceptional" that it should pay Lontex's attorney fees, which exceed $5 million, given that the trial court and Third Circuit had previously held that the Lanham Act case was a close one.
-
December 03, 2025
Sheppard Mullin Lands MoFo IP Atty In Los Angeles
Sheppard Mullin Richter & Hampton LLP announced Wednesday it has bulked up its intellectual property practice with a Los Angeles-based partner who came aboard from Morrison Foerster LLP.
-
December 03, 2025
Fed. Circ. Pushes DC Circ. Not To Rethink Newman Decision
The Federal Circuit has urged the D.C. Circuit to ignore Federal Circuit Judge Pauline Newman's request to rehear a decision upholding the dismissal of her suit against the colleagues who suspended her, saying the judiciary has the right to police its own internal matters.
-
December 02, 2025
Squires Institutes First PTAB Challenges Since Taking Over
U.S. Patent and Trademark Office Director John Squires has instituted four inter partes reviews and two post-grant reviews, the first Patent Trial and Appeal Board challenges to get his sign-off since he took over the institution review process.
-
December 02, 2025
Cher Wins $187K In Royalties In Sonny Bono Estate Dispute
Actress and singer Cher was granted about $187,000 in royalties by a California federal judge who ruled that the money had been retained by her late ex-husband and one-time musical collaborator Sonny Bono's estate improperly.
-
December 02, 2025
14 Ex-Lawmakers Tell USPTO Proposed Rules Violate The Law
A group of 14 former members of Congress, including America Invents Act sponsor Patrick Leahy, has told the U.S. Patent and Trademark Office that the agency's proposal to restrict many patent challenges "violates foundational American legal principles and the AIA."
-
December 02, 2025
Lyft Gets Albright To Invalidate Some Ride-Hailing Patents
A Texas federal judge has found that three of Quartz Auto Technologies' patents Lyft Inc. has been accused of infringing are not patentable, after the ride-hailing giant said they were ineligible for patent protection under the U.S. Supreme Court's Alice standard.
-
December 02, 2025
Citadel Securities Can't Duck Microchip Patent Claims
An Illinois federal judge has denied Citadel Securities' attempt to escape a software company's patent infringement claims related to computer microchips, saying she was not convinced that the patents at issue were too abstract to be valid.
-
December 02, 2025
Tesla Joins Fight At Fed. Circ. Against PTAB Policy Changes
Tesla has become the latest company to head to the Federal Circuit to challenge U.S. Patent and Trademark Office changes to the institution process at the Patent Trial and Appeal Board, saying the office is putting up "arbitrary roadblocks."
-
December 02, 2025
Fed. Circ. Erases $41.8M Verdict Over Seagen Cancer Drug IP
The Federal Circuit in a precedential opinion Tuesday reversed a $41.8 million verdict against Daiichi Sankyo for infringing a Seagen breast cancer treatment patent, saying a lower court should have found that the patent didn't adequately describe the claimed invention or enable a skilled person to use it.
-
December 02, 2025
Startup's Accent Translation Trade Secrets Suit Can Proceed
A California federal judge has denied a technology company's attempt to escape a suit alleging it stole trade secrets related to an accent translation technology from an artificial intelligence startup, saying the tech company's insistence that its rival did not make enough of an effort to defend the secrets does not make for grounds to dismiss the case at this time.
-
December 02, 2025
Miss America Sanctions Bid Must Be Axed, Fla. Court Told
The plaintiffs in a Florida federal court battle over the ownership of the Miss America pageant have pushed back against a sanctions bid against their attorneys, saying the court should reject it because it's "wholly meritless."
-
December 02, 2025
Approach The Bench: Judge Robart On Living Under Threats
It's been nearly nine years since U.S. District Judge James Robart blocked President Donald Trump's 2017 executive order barring travel from seven Muslim-majority countries, and though the judge has had a long career — including groundbreaking patent and securities decisions — he still occasionally gets recognized as that "so-called judge."
-
December 01, 2025
Silver Fern Chemical Tells Jury 3 Workers Stole Trade Secrets
Counsel for chemical distributor Silver Fern Chemical told a Seattle federal jury Monday that three of its salespeople cheated the company out of more than $7 million in revenue by taking confidential customer information to a rival business, kicking off what's expected to be a 12-day trial.
-
December 01, 2025
Fed. Circ. Eyes $162K Fee Award To Vizio In Ramey Case
The Federal Circuit on Monday scrutinized a judge's order that a patent owner represented by embattled firm Ramey LLP must pay Walmart Inc.-owned television maker Vizio Inc. nearly $162,000 in attorney fees, with judges debating if the award was justified based on the plaintiff's settlement offer.
-
December 01, 2025
Merck Wants Fed. Circ. Redo On Decision Backing Axed IP
German drugmaker Merck has asked the Federal Circuit to rethink its decision upholding the invalidation of claims in two patents on the blockbuster multiple sclerosis drug Mavenclad, saying the ruling creates a rule where inventors' work can later be used against them.
-
December 01, 2025
Fed. Circ. Holds IPR Estoppel Doesn't Bind Patent Office
A Patent Trial and Appeal Board trial has no bearing on the U.S. Patent and Trademark Office's ability to separately reevaluate the validity of a patent, the Federal Circuit ruled on Monday.
Expert Analysis
-
FTC, CoStar Cases Against Zillow May Have Broad Impact
Zillow's partnerships with Redfin and Realtor.com have recently triggered dual fronts of legal scrutiny — an antitrust inquiry from the Federal Trade Commission and a mass copyright infringement suit from CoStar — raising complex questions that reach beyond real estate, says Shubha Ghosh at Syracuse University College of Law.
-
Parenting Skills That Can Help Lawyers Thrive Professionally
As kids head back to school, the time is ripe for lawyers who are parents to consider how they can incorporate their parenting skills to build a deep, meaningful and sustainable legal practice, say attorneys at Alston & Bird.
-
Enablement Standard Insights From Fed. Circ. Agilent Ruling
The Federal Circuit's recent enablement standard decision in Agilent v. Synthego underscores three critical takeaways for patent practitioners, including reaffirmation that the enablement inquiry under Section 102 of the Patent Act is distinct from the inquiry under Section 112, say attorneys at MoFo.
-
How WTO's Anti-Suit Injunction Ruling Affects IP Stakeholders
The World Trade Organization's recent ruling in favor of the European Union's challenge to Chinese courts' anti-suit injunction practices should hearten holders of standard-essential patents, while implementers can take solace that they retain mechanisms to distinguish the WTO decision when seeking anti-suit injunctions in U.S. courts, says Michael Franzinger at Dentons.
-
Series
Teaching Trial Advocacy Makes Us Better Lawyers
Teaching trial advocacy skills to other lawyers makes us better litigators because it makes us question our default methods, connect to young attorneys with new perspectives and focus on the needs of the real people at the heart of every trial, say Reuben Guttman, Veronica Finkelstein and Joleen Youngers.
-
Why Civil RICO Claims Are Gaining Traction With Plaintiffs
A Texas federal court's recent $71 million verdict in Point Bridge Capital v. Johnson demonstrates that, when used properly, civil lawsuits under the Racketeering Influenced and Corrupt Organizations Act can be a devastating weapon — and increasingly favorable for plaintiffs, says Akiva Shapiro at Gibson Dunn.
-
You're Out?: Rooftop Views Of Sports Games Raise IP Issues
A high-profile dispute between the Chicago Cubs and a rooftop business adjacent to Wrigley Field strikes at the intersection of sports, intellectual property and Chicago neighborhood tradition, highlighting novel questions that could significantly affect IP rights in the context of live events generally, say attorneys at Troutman Pepper.
-
5 Key Steps To Prepare For Oral Arguments
Whether presenting oral arguments before the U.S. Supreme Court or a local county judge, effective preparation includes the same essential ingredients, from organizing arguments in blocks to maximizing the potential of mock exercises, says Allison Rocker at Baker McKenzie.
-
A Change In Big Pharma Response To FTC Delisting Warnings
While the effect of Federal Trade Commission notices to pharmaceutical companies about allegedly improper patent listings in the U.S. Food and Drug Administration's Orange Book had been de minimis through the end of last year, July data shows an increase in delistings, say Ratib Ali and Celia Lu at Competition Dynamics.
-
9th Circ. Finding That NFTs Are Goods Will Change TM Law
The Ninth Circuit's recent ruling in Yuga Labs v. Ripps establishes that NFTs have real, commercial value under U.S. federal trademark law, a new legal precedent that may significantly influence intellectual property enforcement and marketplace policies regarding digital assets going forward, say attorneys at Wilson Elser.
-
Series
Adapting To Private Practice: From Texas AUSA To BigLaw
As I learned when I transitioned from an assistant U.S. attorney to a BigLaw partner, the move from government to private practice is not without its hurdles, but it offers immense potential for growth and the opportunity to use highly transferable skills developed in public service, says Jeffery Vaden at Bracewell.
-
Data Undermines USPTO's 'Settled Expectations' Doctrine
An analysis of inter partes review proceedings filed since 2012 appears to refute the U.S. Patent and Trademark Office's recent stance that patent owners develop a strong settled expectation that their patents will not be challenged after being in force for six years, say Jonathan DeFosse and Samuel Smith at Sheppard Mullin, and Kenzo Kasai at NGB Corp.
-
Advice For 1st-Gen Lawyers Entering The Legal Profession
Nikki Hurtado at The Ferraro Law Firm tells her story of being a first-generation lawyer and how others who begin their professional journeys without the benefit of playbooks handed down by relatives can turn this disadvantage into their greatest strength.
-
Fed. Circ. In July: Instability In IPR Requirements
The Federal Circuit's decision in Shockwave v. Cardiovascular last month provided an important, albeit short-lived, clarification to the type of evidence that can be used in an inter partes review challenge, say attorneys at Knobbe Martens.
-
Structuring Noncompetes In License And Collaboration Deals
As companies grappling with coming patent cliffs look to mergers and acquisitions to compensate, contracting parties assessing biopharma license and collaboration agreements should prepare to agree on noncompetes that ensure the parties' respective objectives are met and that their incentives are aligned, both under their collaboration and beyond, says Jeff Jay at Freshfields.